RxDoctor Payments Data

Daniel Smith

Aiken, SCNPI 1629027628

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 25.3% of the total. Reporting peaked in 2019 at $1,208 and has fallen 75.9% since, to $291 in 2025.

$3,760in general payments, 2019–2025

Across 140 payments — averaging $26.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$952
  • Bausch & Lomb Americas Inc.$641
  • AbbVie$490
  • Johnson & Johnson Surgical Vision, Inc.$332
  • Mallinckrodt Hospital Products Inc.$312
  • Alcon$216
  • plus $817 from 10 others

What the payments were for

  • Food & beverage$3,760100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →